Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Johan Lanng Nielsen"'
Autor:
Anders Själander, Johan Lanng Nielsen, Henrik Hjorth-Hansen, Satu Mustjoki, Kari Remes, Hans Ehrencrona, Ole Weiss Bjerrum, Anders Almqvist, Mats Björeman, Berit Markevärn, Fredrik Sandin, Franz Gruber, Kristina Myhr-Eriksson, Claes Malm, Max Flogegard, Arnon Nagler, V Kairisto, Ulla Strömberg, Perttu Koskenvesa, Anders Lindblom, Kimmo Porkka, Karin Olsson, Marjatta Sinisalo, Jesper Stentoft, Tobias Gedde-Dahl, Bengt Simonsson, Lotta Ohm, Anu Räsänen
Publikováno v:
Simonsson, B, Gedde-Dahl, T, Markevärn, B, Remes, K, Stentoft, J, Almqvist, A, Björeman, M, Flogegård, M, Koskenvesa, P, Lindblom, A, Malm, C, Mustjoki, S, Myhr-Eriksson, K, Ohm, L, Räsänen, A, Sinisalo, M, Själander, A, Strömberg, U, Bjerrum, O W, Ehrencrona, H, Gruber, F, Kairisto, V, Olsson, K, Sandin, F, Nagler, A, Nielsen, J L, Hjorth-Hansen, H, Porkka, K & Nordic CML Study Group 2011, ' Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low-or intermediate-risk chronic myeloid leukemia ', Ironic Blood, vol. 118, no. 12, pp. 3228-35 . https://doi.org/10.1182/blood-2011-02-336685
Biologic and clinical observations suggest that combining imatinib with IFN-α may improve treatment outcome in chronic myeloid leukemia (CML). We randomized newly diagnosed chronic-phase CML patients with a low or intermediate Sokal risk score and i
Publikováno v:
Acta Pathologica Microbiologica Scandinavica Series A :Pathology. :209-216
The central nervous system has been examined in a consecutive autopsy material of 100 adult patients with acute (N = 67) or chronic (N = 33) leukaemia. In all patients the disease was active at the time of death, infiltrating several organs, and in 4
Publikováno v:
Aalborg University
The in vitro immune functions of peripheral blood lymphocytes have been studied in 70 splenectomized patients. 45 patients were splenectomized due to traumatic rupture of the spleen; in 22 of these patients residual splenic tissue was detected, emplo
Publikováno v:
European Journal of Haematology. 49:67-70
Eleven previously untreated patients with chronic-phase Philadelphia-chromosome-positive chronic myelogenous leukemia were treated with cytotoxic chemotherapy followed by interferon-alfa-2b (IFN-alpha) maintenance. Initial chemotherapy consisted of t
Publikováno v:
Scandinavian Journal of Haematology. 27:51-56
Splenosis or ectopic spleens were detected in 22 of 45 patients splenectomized after either abdominal trauma or accidental lesions of the spleen during operation. The incidence of ectopic spleen tissue in various groups of splenectomized patients has
Publikováno v:
European Journal of Haematology. 58:104-108
The main difference between monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) is the presence of lytic bone destructions in the latter. About 20% of MGUS patients develop MM, and histomorphometric studies have shown
Publikováno v:
Scandinavian Journal of Haematology. 24:80-86
A case of acquired hypogammaglobulinaemia has been examined. Total and differential leucocyte counts and distribution were normal as were the lymphocyte sub-populations when defined by surface membrane immunoglobulin, E-, EA- and EAC-rosette techniqu
Publikováno v:
Scandinavian Journal of Haematology. 30:194-200
Total haemolytic complement activity, C2, C5, total alternative pathway activity, factor B, and C3d were measured in 85 splenectomized patients from 1 month to 32 years after splenectomy. Furthermore the patients were investigated for circulating imm
Autor:
François Guilhot, Laurie Letvak, Richard A. Larson, Bayard L. Powell, Hermine Agis, Norbert Gattermann, Francisco Cervantes, Andreas Hochhaus, Brian J. Druker, Richard T. Silver, Hagop M. Kantarjian, Charlene So, Bengt Simonsson, Thea Kolsen Fischer, Jerald P. Radich, John D. Shepherd, Johan Lanng Nielsen, Alois Gratwohl, Jan J. Cornelissen, Insa Gathmann, Stephen G. O'Brien, Janice Gabrilove, Josy Reiffers, Michael W. Deininger, Kerry Taylor, Richard Stone, Michele Baccarani, Philippe Rousselot, Gregor Verhoef, John M. Goldman, Giuseppe Saglio, Timothy P. Hughes
Publikováno v:
New England Journal of Medicine, 355(23), 2408-2417. Massachussetts Medical Society
Druker, B J, Guilhot, F, O'Brien, S G, Gathmann, I, Kantarjian, H, Gattermann, N, Deiniger, M W, Silver, R T, Goldmann, J M, Stone, R M, Cervantes, F, Hochhaus, A, Powell, B L, Gabrilove, J L, Rousselot, P, Reiffers, J, Cornelissen, J J, Hughes, T, Agis, H, Fischer, T, Verhoef, G, Shepherd, J, Saglio, G, Gratwohl, A, Nielsen, J L, Radich, J P, Simonsson, B, Taylor, K, Baccarani, M, So, C, Letvak, L & larson, R A 2007, ' Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia. ', N. Engl. J. Med., vol. 355, no. 23, pp. 2408-2417 .
Druker, B J, Guilhot, F, O'Brien, S G, Gathmann, I, Kantarjian, H, Gattermann, N, Deiniger, M W, Silver, R T, Goldmann, J M, Stone, R M, Cervantes, F, Hochhaus, A, Powell, B L, Gabrilove, J L, Rousselot, P, Reiffers, J, Cornelissen, J J, Hughes, T, Agis, H, Fischer, T, Verhoef, G, Shepherd, J, Saglio, G, Gratwohl, A, Nielsen, J L, Radich, J P, Simonsson, B, Taylor, K, Baccarani, M, So, C, Letvak, L & larson, R A 2007, ' Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia. ', N. Engl. J. Med., vol. 355, no. 23, pp. 2408-2417 .
The cause of chronic myeloid leukemia (CML) is a constitutively active BCR-ABL tyrosine kinase. Imatinib inhibits this kinase, and in a short-term study was superior to interferon alfa plus cytarabine for newly diagnosed CML in the chronic phase. For
Autor:
Bjarne Jensen, Henrik Birgens, Claudia Schöllkopf, Bjarne Egelund Christensen, Lars Kjeldsen, Ellen Birkerod Taaning, B. Pedersen, Tobias Wirenfeldt Klausen, Johan Lanng Nielsen, Hans Torben Mourits-Andersen, Ole Weiss Bjerrum
Publikováno v:
Leukemia & Lymphoma. 47:253-260
Chronic cold agglutinin disease (CAD) is an acquired autoimmune hemolytic anemia. Previous therapeutic modalities, including alkylating cytostatics, interferon and prednisolone, have been disappointing. However, several case reports and small-scaled